By InvitationNot Applicable

North American Prodromal Synucleinopathy Consortium

United States500 participantsStarted 2018-08-29

Plain-language summary

This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Idiopathic REM sleep behavior disorder Exclusion Criteria: * REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia, Parkinson's Disease, etc) * Other neurological disorder

What they're measuring

Prodromal Synucleinopathy Rating Scale

Timeframe: 2 years

Trial details

NCT IDNCT03623672

SponsorWashington University School of Medicine

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-07-31

View on ClinicalTrials.gov More REM Sleep Behavior Disorder trials